Belite Bio to move listing to Nasdaq Global Select Market
Belite Bio plans to uplist its shares to the Nasdaq Global Select Market, Seeking Alpha reports. Timing and conditions of the move were not disclosed.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Belite Bio plans to move its shares to the Nasdaq Global Select Market, according to a Seeking Alpha item with a headline about the company seeking a higher listing tier.
The text of the item contains only a standard notice that the content is for information purposes, is not personalized investment advice, and comes from a source that is not a licensed broker or investment bank. It gives no date for the move and no other details.
why it matters
The Global Select Market is Nasdaq's highest tier, with stricter listing requirements. An uplisting usually raises a stock's visibility among large institutional investors, but the actual effect on Belite Bio shares depends on details missing from the source.
tags
instruments
sources
- Belite Bio to uplist to Nasdaq Global Select Market — Seeking Alpha, 19 October 2026 at 10:22 UTC
- Belite Bio Announces Uplisting To The Nasdaq Global Select Market — Reuters, 19 October 2026 at 11:07 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗